Atara insider trading
WebBased on 5 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $22.00 with a high forecast of $31.00 and a low forecast of $5.00. The average price target represents a 694.22% change from the last price of $2.77. Highest Price Target $31.00. Average Price Target $22.00. WebThis page provides a comprehensive analysis of the known insider trading history of Atara Dzikowski. Insiders are officers, directors, or significant investors in a company. It is …
Atara insider trading
Did you know?
http://www.insiderinsights.com/company/atra/atara-biotherapeutics-inc http://openinsider.com/search?q=ATRA
WebTrading Signals for Atara Biotherap with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. ... Insider Trading. Insider Trading Activity Politician Insider Trading. Today's Picks. Chart of the Day … WebSep 20, 2024 · Insider trading is the trading of stocks and securities based on non-public insider information. While insider trading can be done legally, illegal violators can face serious penalties. The SEC ...
WebFind the latest Atara Biotherapeutics, Inc. (ATRA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... the largest insider sales ... WebCEO: Pascal Touchon. Employees: 580. 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO, CA 94080. 650-278-8930. atarabio.com. Atara Biotherapeutics, Inc. develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the ...
WebJul 21, 2024 · Atara Biotherapeutics Inc (NASDAQ:ATRA) was in 20 hedge funds’ portfolios at the end of the first quarter of 2024. The all time high for this statistic is 23. The all time high for this ...
WebApr 13, 2024 · Insider Activity at Atara Biotherapeutics. In other Atara Biotherapeutics news, CEO Pascal Touchon sold 15,679 shares of Atara Biotherapeutics stock in a transaction that occurred on Thursday, March 2nd. The stock was sold at an average price of $3.63, for a total value of $56,914.77. ... Atara Biotherapeutics Trading Down 8.9 %. … eye world ocalaWebMar 3, 2024 · In the last 2 years at Atara Biotherapeutics, Inc, Kristin Yarema has sold an estimated value of $11.07K worth. What is Kristin Yarema's Past Insider Trading? eyeworld optometryWebMar 27, 2024 · In the last 9 years, insiders at Atara Biotherapeutics, Inc have sold an estimated value of $73.39M and bought an estimated value of $10.47M worth of shares. Insider trading is most common in ... does brightline have stockWebApr 12, 2024 · According to the issued ratings of 7 analysts in the last year, the consensus rating for Atara Biotherapeutics stock is Hold based on the current 2 sell ratings, 2 hold ratings and 3 buy ratings for ATRA. The average twelve-month price prediction for Atara Biotherapeutics is $19.25 with a high price target of $50.00 and a low price target of $3.00. eye world optical middle village nyWebAmount: When there is an accurate amount available in the form 4 filing, it will be shown. If an accurate amount is not available, we will show the Estimated Value which is a unique … eyeworld opticsWebData is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the … does brightline have a website for seniorsWebFeb 6, 2024 · Atara Biotherapeutics Inc insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on … does brightline offer senior discounts